That inflammation, immune system activation and imbalance, and cell proliferation and adhesion migration were mainly affected by HLA-DRA, SYK, CTLA4, VAV1, NRAS, and JAK3 signaling pathways was suggested to be the potential molecular mechanism for pulmonary inflammation and fibrosis in ACO. This evidence concerns the gene JAK3 and inflammatory response.